mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.009 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.01 |